Supplementary material: Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating

Fig. S1. Cell cycle population distribution (percentage of cells, %) after treatment with HGNPs@P(MEO2MA-co-OEGMA500) nanoparticles (NPs) for 24 h. Table S1. Percentages of both early and late apoptotic, alive and necrotic cells after treatment with HGNPs@P(MEO2MA-co-OEGMA500) nanoparticles (NPs) fo...

Descripción completa

Detalles Bibliográficos
Autores: Alejo, Teresa, Andreu, Vanesa, Mendoza, Gracia, Sebastián, Víctor, Arruebo, Manuel
Tipo de recurso: conjunto de datos
Fecha de publicación:2018
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/366722
Acceso en línea:http://hdl.handle.net/10261/366722
Access Level:acceso abierto
id ES_6ad10d73ffc27177ea2cd5111691a464
oai_identifier_str oai:digital.csic.es:10261/366722
network_acronym_str ES
network_name_str España
repository_id_str
spelling Supplementary material: Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heatingAlejo, TeresaAndreu, VanesaMendoza, GraciaSebastián, VíctorArruebo, ManuelFig. S1. Cell cycle population distribution (percentage of cells, %) after treatment with HGNPs@P(MEO2MA-co-OEGMA500) nanoparticles (NPs) for 24 h. Table S1. Percentages of both early and late apoptotic, alive and necrotic cells after treatment with HGNPs@P(MEO2MA-co-OEGMA500) nanoparticles (NPs) for 24 h.Peer reviewedElsevier202420242018info:eu-repo/semantics/datasethttp://purl.org/coar/resource_type/c_ddb1application/mswordhttp://hdl.handle.net/10261/366722reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)InglésAlejo, Teresa; Andreu, Vanesa; Mendoza, Gracia; Sebastián, Víctor; Arruebo, Manuel. Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating. https://doi.org/10.1016/j.jcis.2018.03.107. http://hdl.handle.net/10261/366721Noinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3667222026-05-22T06:33:51Z
dc.title.none.fl_str_mv Supplementary material: Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating
title Supplementary material: Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating
spellingShingle Supplementary material: Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating
Alejo, Teresa
title_short Supplementary material: Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating
title_full Supplementary material: Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating
title_fullStr Supplementary material: Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating
title_full_unstemmed Supplementary material: Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating
title_sort Supplementary material: Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating
dc.creator.none.fl_str_mv Alejo, Teresa
Andreu, Vanesa
Mendoza, Gracia
Sebastián, Víctor
Arruebo, Manuel
author Alejo, Teresa
author_facet Alejo, Teresa
Andreu, Vanesa
Mendoza, Gracia
Sebastián, Víctor
Arruebo, Manuel
author_role author
author2 Andreu, Vanesa
Mendoza, Gracia
Sebastián, Víctor
Arruebo, Manuel
author2_role author
author
author
author
description Fig. S1. Cell cycle population distribution (percentage of cells, %) after treatment with HGNPs@P(MEO2MA-co-OEGMA500) nanoparticles (NPs) for 24 h. Table S1. Percentages of both early and late apoptotic, alive and necrotic cells after treatment with HGNPs@P(MEO2MA-co-OEGMA500) nanoparticles (NPs) for 24 h.
publishDate 2018
dc.date.none.fl_str_mv 2018
2024
2024
dc.type.none.fl_str_mv info:eu-repo/semantics/dataset
http://purl.org/coar/resource_type/c_ddb1
format dataset
dc.identifier.none.fl_str_mv http://hdl.handle.net/10261/366722
url http://hdl.handle.net/10261/366722
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Alejo, Teresa; Andreu, Vanesa; Mendoza, Gracia; Sebastián, Víctor; Arruebo, Manuel. Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating. https://doi.org/10.1016/j.jcis.2018.03.107. http://hdl.handle.net/10261/366721
No
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/msword
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC
instname:Consejo Superior de Investigaciones Científicas (CSIC)
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
reponame_str DIGITAL.CSIC. Repositorio Institucional del CSIC
collection DIGITAL.CSIC. Repositorio Institucional del CSIC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869410139788804096
score 15,812429

Similares en LA Referencia